SaluskyI.B., CoburnJ.W., BrillJ., FoleyJ., SlatopolskyE., FineR.N.Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD.Kidney Int.1988; 33: 975–82.
2.
SherrardD.J., HerczG., PeiY., MaloneyN., GreenwoodC., ManuelA.The spectrum of bone disease in endstage renal failure -An evolving disorder.Kidney Int.1993; 43: 436–42.
3.
Rodriguez-PerezJ.C., PlazaC., TorresA., VegaN., AnabitarteA., FernandezA.Low turnover bone disease is the more common form of bone disease in CAPD patients. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in Peritoneal Dialysis.Toronto: Peritoneal Dialysis Bulletin, 1992; 8: 376–80.
4.
GoodmanW.G., SaluskyI.B.Evolution of secondary hyperparathyroidism during daily oral calcitriol therapy in pediatric renal osteodystrophy.Contrib Nephrol.1991; 90: 189–95.
5.
GoodmanW.G., RamirezJ.A., BelinT.R., ChonY., GalesB., SegreG.V.Development of adynamic bone in patients with secondary hyperparathyroidism after in termittent calcitriol therapy.Kidney Int.1994; 46: 1160–6.
6.
SlatopolskyE., WeertsC., ThielanJ., HorstR.L., HarterH., MartinK.J.Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients.J Clin Invest.1984; 74: 2136–43.
7.
QuarlesL.D., YohayD.A., CarrollB.A., SpritzerC.E., MindaS.A., BartholomayD.Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD.Kidney Int.1994; 45: 1710–21.
8.
SaluskyI.B., KuizonB.D., BelinT.R., RamirezJ.A., GalesB., SegreG.V.Intermittent calcitriol therapy in secondary hyperparathyroidism: A comparison between oral and intraperitoneal administration.Kidney Int.1998; 54: 907–14.
9.
SaluskyI.B., FineR.N., NelsonP., BlumenkrantzM.J., KoppleJ.D.Nutritional status of children undergoing continuous ambulatory peritoneal dialysis.Am J Clin Nutr.1983; 38: 599–611.
DelmezJ.A., DouganC.S., GearingB.K., RothsteinM., WindusD.W., RappN.The effects of intraperitoneal calcitriol on calcium and parathyroid hormone.Kidney Int.1987; 31: 795–9.
12.
KuizonB.D., GoodmanW.G., JüppnerH., BoechatI., NelsonP., GalesB.Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD.Kidney Int.1998; 53: 205–11.
13.
AndressD.L., NorrisK.C., CoburnJ.W., SlatopolskyE.A., SherrardD.J.Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure.N Engl J Med.1989; 321: 274–9.
14.
BergerN., MehlsO., SchmittC.P., OhJ.Daily calcitriol but not pulse therapy improves growth in experimental uremia [Abstract].J Am Soc Nephrol.1996; 7: 1787.
